Nicholas Maurice M.D.
Overview
Dr. Nicholas Maurice received his undergraduate degree at the University of Notre Dame in 2007. He earned his medical degree at the University of Pittsburgh School of Medicine in 2012 after additional research training in the Physician Scientist Training Program and as a Howard Hughes Medical Institute (HHMI) Medical Research Fellow. He completed Internal Medicine internship and residency at the University of Michigan Health System in 2015. He then completed his Pulmonary and Critical Care Medicine fellowship at Emory University in 2019 after completing a post-doctoral research fellowship under the mentorship of Dr. Ruxana Sadikot. He thereafter joined the faculty as an Assistant Professor of Medicine. He earned a Research Development Award (RDA) from the Department of Veterans Affairs in 2019 and a national Career Development Award (CDA-2) in 2022. He conducts laboratory research investigating the lung epithelial host response to bacterial pneumonia and investigates possible therapeutic approaches to augment this host response to bacterial pathogens. He practices clinical pulmonary and critical care medicine at the Atlanta VA Health Care System (AVAHCS), where he also serves as Director of the AVAHCS Lung Cancer Screening program, served as the site director for the VA Partnership to Increase Access to Lung Cancer Screening (VA-PALS) program, and serves as a co-Investigator within the VA Lung Precision Oncology Program (LPOP) VISN7 Southeastern .Consortium.
Academic Appointment
- Assistant Professor of Medicine, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine
Education
Degrees
- M.D. from University of Pittsburgh School of Medicine
- B.S. from University of Notre Dame
Research
Publications
-
Health Care Provider Practices and Perceptions of Biomarker Testing in US Veterans With Non-Small Cell Lung Cancer.
Chest Volume: 167 Page(s): 630 - 635
02/01/2025 Authors: Vlachos E; Fox A; Dell'Italia J; Maurice N; Rubinstein I; Tanner NT -
Mitochondrial Dysfunction in Bacterial Infections.
Pathogens Volume: 12
08/01/2023 Authors: Maurice NM; Sadikot RT -
Lung cancer screening at the VA: Past, present and future.
Semin Oncol Volume: 49 Page(s): 206 - 212
06/01/2022 Authors: Maurice NM; Tanner NT -
The Effect of PGC-1alpha-SIRT3 Pathway Activation on Pseudomonas aeruginosa Infection.
Pathogens Volume: 11
01/01/2023 Authors: Maurice NM; Bedi B; Yuan Z; Lin K-C; Goldberg JB; Hart CM; Bailey KL; Sadikot RT -
Oxidative Mitochondrial DNA Damage in Lung Epithelial Cells Induced by Non-Pore-Forming Action of the Pneumococcal Virulence Factor Pneumolysin
Volume: 203
05/01/2021 Authors: Maurice NM; Bedi B; Yuan Z; Koval M; Vidal JE; Hart C; Sadikot RT -
UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis.
Clin Sci (Lond) Volume: 134 Page(s): 1911 - 1934
07/31/2020 Authors: Bedi B; Lin K-C; Maurice NM; Yuan Z; Bijli K; Koval M; Hart CM; Goldberg JB; Stecenko A; Sadikot RT -
STREPTOCOCCUS PNEUMONIAE-INDUCED EPITHELIAL BARRIER FUNCTION IS MEDIATED BY MITOCHONDRIAL REACTIVE OXYGEN SPECIES GENERATION AND ATTENUATED BY A MITOCHONDRIALLY-TARGETED ANTIOXIDANT
Volume: 68 Page(s): 603 - 603
02/01/2020 Authors: Maurice NM; Bedi B; Yuan Z; Koval M; Hart M; Sadikot RT -
UPR Induced Modulation of Host Defense by P. Aeruginosa in Cystic Fibrosis
Volume: 201
01/01/2020 Authors: Bedi B; Lin K; Maurice NM; Goldberg JB; Stecenko AA; Sadikot RT -
Streptococcus Pneumoniae-Induced Epithelial Barrier Dysfunction Is Mediated by Mitochondrial Reactive Oxygen Species Generation and Attenuated by a Mitochondrially-Targeted Antioxidant
Volume: 201
01/01/2020 Authors: Maurice NM; Bedi B; Yuan Z; Koval M; Hart C; Sadikot RT -
Pseudomonas aeruginosa Induced Host Epithelial Cell Mitochondrial Dysfunction.
Sci Rep Volume: 9 Page(s): 11929
08/15/2019 Authors: Maurice NM; Bedi B; Yuan Z; Goldberg JB; Koval M; Hart CM; Sadikot RT